{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T22:48:16Z","timestamp":1761518896574},"reference-count":12,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[1996,12,1]],"date-time":"1996-12-01T00:00:00Z","timestamp":849398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Mayo Clinic Proceedings"],"published-print":{"date-parts":[[1996,12]]},"DOI":"10.4065\/71.12.1145","type":"journal-article","created":{"date-parts":[[2009,1,24]],"date-time":"2009-01-24T01:08:23Z","timestamp":1232759303000},"page":"1145-1149","source":"Crossref","is-referenced-by-count":5,"title":["Pseudocarcinoid Syndrome Associated With Hypogonadism and Response to Testosterone Therapy"],"prefix":"10.4065","volume":"71","author":[{"given":"K.M. Mohamed","family":"Shakir","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. Zuhdi","family":"Jasser","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ann K.","family":"Yoshihashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"suffix":"III","given":"Almond J.","family":"Drake","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John F.","family":"Eisold","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.4065\/71.12.1145_bib1","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1002\/1097-0142(197508)36:2<560::AID-CNCR2820360235>3.0.CO;2-4","article-title":"Carcinoid tumors: an analysis of 2,837 cases","volume":"36","author":"Godwin","year":"1975","journal-title":"Cancer"},{"key":"10.4065\/71.12.1145_bib2","first-page":"2803","article-title":"Neuroendocrine tumors of carcinoid variety","volume":"Vol 3","author":"Vinik","year":"1995"},{"key":"10.4065\/71.12.1145_bib3","first-page":"237","article-title":"Carcinoid tumors and syndrome","volume":"14","author":"Feldman","year":"1987","journal-title":"Semin Oncol"},{"key":"10.4065\/71.12.1145_bib4","doi-asserted-by":"crossref","first-page":"468","DOI":"10.7326\/0003-4819-95-4-468","article-title":"Flushing reactions: consequences and mechanisms","volume":"95","author":"Wilkin","year":"1981","journal-title":"Ann Intern Med"},{"key":"10.4065\/71.12.1145_bib5","doi-asserted-by":"crossref","first-page":"2614","DOI":"10.1001\/archinte.1988.00380120074015","article-title":"Distinguishing features of idiopathic flushing and carcinoid syndrome","volume":"148","author":"Aldrich","year":"1988","journal-title":"Arch Intern Med"},{"key":"10.4065\/71.12.1145_bib6","first-page":"840","article-title":"Urinary serotonin in the diagnosis of carcinoid tumors","volume":"32","author":"Feldman","year":"1986","journal-title":"ClinChem"},{"key":"10.4065\/71.12.1145_bib7","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1097\/00000658-198501000-00012","article-title":"The pentagastrin test in the diagnosis of the carcinoid syndrome: blockade of gastrointestinal symptoms by ketanserin","volume":"201","author":"Ahlman","year":"1985","journal-title":"Ann Surg"},{"key":"10.4065\/71.12.1145_bib8","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0889-8529(18)30122-1","article-title":"Management of individual tumor syndromes: medullary thyroid carcinoma and hyper-parathyroidism","volume":"23","author":"Snow","year":"1994","journal-title":"Endocrinol Metab Clin North Am"},{"key":"10.4065\/71.12.1145_bib9","series-title":"Williams Textbook of Endocrinology","first-page":"1619","article-title":"Disorders of vasodilator hormones: the carcinoid syndrome and mastocytosis","author":"Roberts","year":"1992"},{"key":"10.4065\/71.12.1145_bib10","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/0006-291X(85)91772-3","article-title":"Neuropeptide K: a major tachykinin in plasma and tumor tissues from carcinoid patients","volume":"131","author":"Theodorsson-Norheim","year":"1985","journal-title":"Biochem Biophys Res Commun"},{"issue":"Suppl6B","key":"10.4065\/71.12.1145_bib11","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/0002-9343(86)90583-8","article-title":"Role of neuropeptides and serotonin in the diagnosis of carcinoid tumors","volume":"81","author":"Feldman","year":"1986","journal-title":"Am J Med"},{"key":"10.4065\/71.12.1145_bib12","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1210\/jcem-70-6-1702","article-title":"Plasma substance-P in neuroendocrine tumors and idiopathic flushing: the value of pentagastrin stimulation tests and the effects of somatostatin analog","volume":"70","author":"Vinik","year":"1990","journal-title":"J Clin Endocrinol Metab"}],"container-title":["Mayo Clinic Proceedings"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025619611646946?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025619611646946?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,17]],"date-time":"2019-05-17T13:52:32Z","timestamp":1558101152000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0025619611646946"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1996,12]]},"references-count":12,"journal-issue":{"issue":"12","published-print":{"date-parts":[[1996,12]]}},"alternative-id":["S0025619611646946"],"URL":"https:\/\/doi.org\/10.4065\/71.12.1145","relation":{},"ISSN":["0025-6196"],"issn-type":[{"value":"0025-6196","type":"print"}],"subject":[],"published":{"date-parts":[[1996,12]]}}}